Gara Jalqabaatti › Astrocytoma › Massachusetts
Qorannoo klinikaalii Astrocytoma Massachusetts keessatti
Qorannoo 13 Astrocytoma f Massachusetts keessatti hirmaatuu jiru.
Magaalota Massachusetts keessatti
Takkalaa qorannoo (Ingiliffa)
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
- Research Site, Boston
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 hanga 130 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05417594Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
- Tufts Medical Center, Boston
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07215910Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
- Tufts Medical Center, Boston
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06047379Targeted Pediatric High-Grade Glioma Therapy
- Dana-Farber Cancer Institute, Boston
Namoota walitti qabaa jiraQorannoo ilaalaa
12 Months – 39 Years · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT05839379Serial MRI Scans During Radiation Therapy
- Brigham and Women Hospital, Boston
- Dana Farber Cancer Institute, Boston
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT04188535Study of Olutasidenib and Temozolomide in HGG
- Susan Chi, Boston
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 12 hanga 39 · Saalaa hunda · Haaromfame 01-Ful-2026 · NCT06161974SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Hag-2026 · NCT05303519Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
- Dana-Farber Cancer Institute, Boston
Namoota walitti qabaa jiraSadarkaa jalqabaa 1Hojjettoota fayyaa simatamoo
Umuriin 1 hanga 21 · Saalaa hunda · Haaromfame 29-Wax-2026 · NCT06333899Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- Dana-Farber Cancer Institute, Boston
Namoota walitti qabaa jiraSadarkaa 2
12 Months – 39 Years · Saalaa hunda · Haaromfame 29-Cam-2026 · NCT05843253Implantable Microdevice In Primary Brain Tumors
- Brigham and Women's Hospital, Boston
Namoota walitti qabaa jiraSadarkaa jalqabaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ado-2025 · NCT04135807The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
- Massachusetts General Hospital, Boston
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 90 · Saalaa hunda · Haaromfame 28-Gur-2024 · NCT06283927The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
- Massachusetts General Hospital, Boston
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 90 · Saalaa hunda · Haaromfame 22-Gur-2024 · NCT06118723The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma
- Massachusetts General Hospital, Boston
Namoota walitti qabaa jiraQorannoo ilaalaa
Hanga umuriin 90 · Saalaa hunda · Haaromfame 22-Gur-2024 · NCT06273176Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.